DAMAI ENT Surges Over 4% Intraday, Poised to Fully Benefit from Consumption Structure Upgrade

Deep News
01/20

DAMAI ENT (01060) rose more than 4% during the trading session. As of the time of writing, the stock was up 3.26%, trading at HK$0.95 with a turnover of HK$99.4266 million.

Recently, at the 2025 Annual Meeting of the Exhibition Exchange Professional Committee of the Chinese Museum Association held in Hangzhou, the China Cultural Heritage Exchange Center, in collaboration with DAMAI ENT's "Yi Zhan Hong Tu" and the cultural museum service provider "Zhong Chuang Yun Qi," jointly launched the "Cultural Context Integration, Digital Intelligence Advancement - Launch Plan," also known as the 2026 Museum "Special Exhibition Cooperation Plan." This initiative aims to partner with museums across China to create innovative cultural museum special exhibition projects. This marks DAMAI ENT's first invitation to participate in the conference, signaling its official entry into the museum sector. Moving forward, DAMAI ENT plans to deepen its collaboration with museums across three key areas: exhibition marketing, content production, and ticketing systems.

CITIC Securities points out that DAMAI ENT's IP business is performing strongly. Domestically, its performance business is expected to benefit from policy changes, while internationally, it stands to gain from the implementation of hosted projects. Furthermore, the company is anticipated to have significant involvement in both production and distribution during the 2026 Spring Festival season.

Previously, Western Securities indicated that the company is well-positioned in two high-growth sectors: live performances and IP derivatives. Its ticketing business provides a stable fundamental base, and Alibaba Fish is expected to contribute earnings elasticity, allowing the company to fully benefit from the ongoing recovery and structural upgrade in offline entertainment consumption.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10